Newsletter Signup x
Childhood cancer survival rates still vary across Europe and other developed countries, but the reasons why are not fully understood. Until now, teasing out the clues that could explain these variations has not been feasible. This is due to the lack of information on how far cancers have spread at diagnosis (tumour stage) and the different ways that this is recorded in different countries. Prof. Kathy Pritchard-Jones and her international team will overcome this issue by standardising cancer data on tumour stage across multiple European countries and further abroad to allow meaningful comparisons. Their findings could help countries to understand and improve childhood cancer survival rates in their own nations.
“BENCHISTA” - Benchmarking International Survival by Toronto stAge
Prof. Kathy Pritchard-Jones and Dr Gemma Gatta
University College London, UCL Great Ormond Street Institute of Child Health; and Fondazione IRCCS, Istituto Nazionale dei Tumori, Milan
London, WC1N 1EH; and Milan, 20133 Milano MI
1 January 2021
30 months
£349,746.50
Patient Story – Mia
Mia was diagnosed with acute lymphoblastic leukaemia just after her fourth birthday. Her dad Andy tells their story so
Read morePatient Story – Ceylian
Ceylian was diagnosed with Ewing sarcoma in 2017 when he was just two years old. Tragically,
Read morePatient Story – Abbie
Abbie was diagnosed with acute myeloid leukaemia in January 2018 when she was eight years old. Her dad Paul
Read more